NEW YORK (GenomeWeb News) - Response Genetics today said it will work with the University of California, San Francisco, on a two-year research study aimed at developing a diagnostic test kit for pancreatic cancer.
 
The company said the study will combine data from patient outcomes with genetic information from formalin-fixed paraffin-embedded samples of pancreatic tissue provided by UCSF.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.